Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins. CCG-63802 inhibits the interaction between RGS4 and Galpha with an IC50 value of 1.4 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 57.00 | |
10 mg | In stock | $ 97.00 | |
25 mg | In stock | $ 213.00 | |
50 mg | In stock | $ 395.00 |
Description | CCG-63802 is a reversible small-molecule inhibitor of regulator of G protein signaling (RGS) proteins. CCG-63802 inhibits the interaction between RGS4 and Galpha with an IC50 value of 1.4 μM. |
Targets&IC50 | RGS4:1.4 μM |
In vitro | CCG-63802 inhibits GTPase accelerating protein activity of RGS4 and blocks its interaction with Gαo. |
Molecular Weight | 450.51 |
Formula | C26H18N4O2S |
CAS No. | 620112-78-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 1.67 mg/mL (3.71 mM), Sonification and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CCG-63802 620112-78-9 GPCR/G Protein GTPase inflammation CCG 63802 RGS reversible selective Regulator of G-protein Signaling Regulators of G-protein Signaling inhibit CCG63802 Inhibitor RGS Protein inhibitor